IAMAI Trademark

Trademark Overview

On Thursday, March 9, 2023, a trademark application was filed for IAMAI with the United States Patent and Trademark Office. The USPTO has given the IAMAI trademark a serial number of 97831342. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 30, 2024. This trademark is owned by Xillix. The IAMAI trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing advertising and marketing services to the pharmaceutical and medical industries
iamai

General Information

Serial Number97831342
Word MarkIAMAI
Filing DateThursday, March 9, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 4, 2024

Trademark Statements

Goods and ServicesProviding advertising and marketing services to the pharmaceutical and medical industries

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, March 29, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXillix
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorth Cape May, NJ 08204
Party NameXillix
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorth Cape May, NJ 08204

Trademark Events

Event DateEvent Description
Monday, March 13, 2023NEW APPLICATION ENTERED
Wednesday, March 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 12, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 12, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 6, 2023ASSIGNED TO EXAMINER
Monday, December 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 6, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 6, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 15, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 2, 2024ASSIGNED TO LIE

Related Keywords

iamai medical industries pharmaceutical services advertising marketing providing